Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Inventory (2017 - 2025)

Puma Biotechnology's Change in Inventory history spans 9 years, with the latest figure at -$4.0 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 165.46% year-over-year to -$4.0 million; the TTM value through Dec 2025 reached -$3.2 million, down 295.19%, while the annual FY2025 figure was -$3.2 million, 295.19% down from the prior year.
  • Change in Inventory reached -$4.0 million in Q4 2025 per PBYI's latest filing, down from $885000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $6.1 million in Q4 2024 to a low of -$6.4 million in Q3 2024.
  • Average Change in Inventory over 5 years is $103050.0, with a median of -$111000.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: soared 3278.74% in 2021, then crashed 854.64% in 2022.
  • A 5-year view of Change in Inventory shows it stood at -$97000.0 in 2021, then plummeted by 854.64% to -$926000.0 in 2022, then soared by 251.3% to $1.4 million in 2023, then soared by 331.91% to $6.1 million in 2024, then tumbled by 165.46% to -$4.0 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Change in Inventory are -$4.0 million (Q4 2025), $885000.0 (Q3 2025), and -$160000.0 (Q2 2025).